Xtandi 40 MG tablet 120S

Ended Awarded

Contract number
SPE2DB25FYX44
Awardee
Awarding agency
Obligated
$65,696

Award facts

Contract value 100% obligated
$65,695.52 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order valued at $65,695.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg tablets (120 count). The award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products to support Department of Defense healthcare facilities worldwide.

Xtandi, an oncology treatment medication, represents one of many specialty pharmaceutical products that DMS Pharmaceutical Group distributes to military and federal healthcare systems across the nation. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing delivery orders for branded and generic prescription drugs, biologics, vaccines, and medical consumables. This particular award demonstrates the company's ongoing role in fulfilling the Defense Logistics Agency's pharmaceutical procurement needs for military health facilities, with the performance location designated as Park Ridge, Illinois.

Quick answers

Who was awarded contract SPE2DB25FYX44?

SPE2DB25FYX44 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 25, 2025.

How much is contract SPE2DB25FYX44 worth?

The government has obligated $65,696 on SPE2DB25FYX44.

Is contract SPE2DB25FYX44 an order under another contract?

Yes. SPE2DB25FYX44 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.

Was contract SPE2DB25FYX44 competed?

The extent of competition for SPE2DB25FYX44 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award